07393155 false community pharmacy 2024-10-01 2025-09-30 http://www.companieshouse.gov.uk/2024-09-30 http://www.companieshouse.gov.uk/pt:ShareCapital 2024-09-30 http://www.companieshouse.gov.uk/cd:Director1 2024-10-01 2025-09-30 http://www.companieshouse.gov.uk/pt:CommercialMotorVehicles 2024-09-30 http://www.companieshouse.gov.uk/pt:ShareCapital 2025-09-30 http://www.companieshouse.gov.uk/cd:Director2 2024-10-01 2025-09-30 http://www.companieshouse.gov.uk/pt:FurnitureFittings 2024-09-30 http://www.companieshouse.gov.uk/pt:CommercialMotorVehicles 2025-09-30 http://www.companieshouse.gov.uk/pt:FurnitureFittings 2025-09-30 http://www.companieshouse.gov.uk/cd:OrdinaryShareClass1 2024-10-01 2025-09-30 http://www.companieshouse.gov.uk/cd:RegisteredOffice 2024-10-01 2025-09-30 http://www.companieshouse.gov.uk/pt:NetGoodwill 2025-09-30 http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments 2025-09-30 http://www.companieshouse.gov.uk/pt:NetGoodwill 2024-10-01 2025-09-30 http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments 2024-09-30 http://www.companieshouse.gov.uk/2024-10-01 2025-09-30 http://www.companieshouse.gov.uk/2024-09-30 http://www.companieshouse.gov.uk/cd:FRS102 2024-10-01 2025-09-30 http://www.companieshouse.gov.uk/2025-09-30 http://www.companieshouse.gov.uk/cd:FullAccounts 2024-10-01 2025-09-30 http://www.companieshouse.gov.uk/pt:LandBuildings 2024-09-30 http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 http://www.companieshouse.gov.uk/pt:LandBuildings 2025-09-30 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 07393155
Sunrise Pharma Limited
ACCOUNTS
FOR THE YEAR ENDED 30/09/2025
Prepared By:
CLS & Co
Accountants
24 Roundbush Crescent
Caerwent
Caldicot
Monmouthshire
NP26 5AG

Sunrise Pharma Limited

ACCOUNTS
FOR THE YEAR ENDED 30/09/2025
DIRECTORS
S K Narang
R T Smith
REGISTERED OFFICE
24 Roundbush Crescent
Caerwent
Monmouthshire
NP26 5AG
COMPANY DETAILS
Private company limited by shares registered in EW - England and Wales, registered number 07393155
ACCOUNTANTS
CLS & Co
Accountants
24 Roundbush Crescent
Caerwent
Caldicot
Monmouthshire
NP26 5AG

Sunrise Pharma Limited

ACCOUNTS
FOR THE YEAR ENDED 30/09/2025
CONTENTS |  |
|  | Page
Directors' Report |  | -
Accountants' Report |  | -
Statement Of Comprehensive Income |  | -
Balance Sheet |  | 3
Notes To The Accounts |  | 4
The following do not form part of the statutory financial statements: |  |
Trading And Profit And Loss Account |  | -
Profit And Loss Account Summaries |  | -

Sunrise Pharma Limited

BALANCE SHEET AT 30/09/2025
|  |  |  |  |  | 2025 |  |  |  | 2024
|  | Notes |  |  |  | £ |  |  |  | £
FIXED ASSETS |  |  |  |  |  |  |  |  |  |
Tangible assets |  | 4 |  |  |  | 125,968 |  |  |  | 128,282
CURRENT ASSETS |  |  |  |  |  |  |  |  |  |
Stock |  |  |  | 34,943 |  |  |  | 35,264 |  |
Debtors |  | 6 |  | 185,118 |  |  |  | 196,734 |  |
Cash at bank and in hand |  |  |  | 172,903 |  |  |  | 96,586 |  |
|  |  |  | 392,964 |  |  |  | 328,584 |  |
CREDITORS: Amounts falling due within one year |  | 7 |  | 493,332 |  |  |  | 485,754 |  |
NET CURRENT LIABILITIES |  |  |  |  |  | (100,368) |  |  |  | (157,170)
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  |  |  |  | 25,600 |  |  |  | (28,888)
PROVISIONS FOR LIABILITIES AND CHARGES |  | 8 |  |  |  | 818 |  |  |  | -
NET ASSETS / (LIABILITIES) |  |  |  |  |  | 24,782 |  |  |  | (28,888)
CAPITAL AND RESERVES |  |  |  |  |  |  |  |  |  |
Called up share capital |  | 9 |  |  |  | 100 |  |  |  | 100
Profit and loss account |  |  |  |  |  | 24,682 |  |  |  | (28,988)
SHAREHOLDERS' FUNDS |  |  |  |  |  | 24,782 |  |  |  | (28,888)
For the year ending 30/09/2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have decided not to deliver to the registrar a copy of the company's profit and loss account.
Approved by the board on 23/01/2026 and signed on their behalf by |  |  |  |  |  |  |  |  |  |
............................. |  |  |  |  |  |  |  |  |  |
S K Narang |  |  |  |  |  |  |  |  |  |
Director |  |  |  |  |  |  |  |  |  |

Sunrise Pharma Limited

NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 30/09/2025

1. ACCOUNTING POLICIES

1a. Basis Of Accounting
The accounts have been prepared under the historical cost convention.
The accounts have been prepared in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 .

1b. Depreciation |  |
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.
Land And Buildings |  | straight line 2%
Commercial Vehicles |  | straight line 25%
Fixtures and Fittings |  | straight line 15%

1c. Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.
When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stocks recognised as an expense in the period in which the reversal occurs.

1d. Pension Costs
The company operates a defined contribution pension scheme. The pension charge represents the amounts payable by the company to the fund in respect of the year.

1e. Goodwill
Goodwill arising in connection with the acquisition of businesses is capitalised and amortised over its estimated economic life to a maximum of 20 years. Goodwill is reviewed annually for impairment if events or changes in circumstances indicate that the carrying value may not be recoverable.

Sunrise Pharma Limited

2. EMPLOYEES |  |  |  |  |  |
|  |  |  | 2025 |  | 2024
|  |  |  | No. |  | No.
Average number of employees |  |  |  | 6 |  | 6

3. INTANGIBLE FIXED ASSETS |  |  |  |
|  | Purchased |  |
|  | Goodwill |  | Total
|  | £ |  | £
Cost |  |  |  |
At 01/10/2024 |  | 957,317 |  | 957,317
At 30/09/2025 |  | 957,317 |  | 957,317
Depreciation |  |  |  |
At 01/10/2024 |  | 957,317 |  | 957,317
At 30/09/2025 |  | 957,317 |  | 957,317
Net Book Amounts |  |  |  |
At 30/09/2025 |  | - |  | -

4. TANGIBLE FIXED ASSETS |  |  |  |  |  |  |  |
|  | Land And |  | Commercial |  | Fixtures |  |
|  | Buildings |  | Vehicles |  | and Fittings |  | Total
|  | £ |  | £ |  | £ |  | £
Cost |  |  |  |  |  |  |  |
At 01/10/2024 |  | 141,791 |  | 9,542 |  | 34,434 |  | 185,767
At 30/09/2025 |  | 141,791 |  | 9,542 |  | 34,434 |  | 185,767
Depreciation |  |  |  |  |  |  |  |
At 01/10/2024 |  | 17,805 |  | 8,348 |  | 31,332 |  | 57,485
For the year |  | 1,240 |  | 298 |  | 776 |  | 2,314
At 30/09/2025 |  | 19,045 |  | 8,646 |  | 32,108 |  | 59,799
Net Book Amounts |  |  |  |  |  |  |  |
At 30/09/2025 |  | 122,746 |  | 896 |  | 2,326 |  | 125,968
At 30/09/2024 |  | 123,986 |  | 1,194 |  | 3,102 |  | 128,282

5. STOCK |  |  |  | 2025 |  | 2024
|  |  |  | £ |  | £
Stock comprises: |  |  |  |  |  |
Stock |  |  |  | 34,943 |  | 35,264
|  |  |  | 34,943 |  | 35,264

Sunrise Pharma Limited

6. DEBTORS |  |  |  | 2025 |  | 2024
|  |  |  | £ |  | £
Amounts falling due within one year |  |  |  |  |  |
Trade debtors |  |  |  | 156,231 |  | 165,675
VAT |  |  |  | 28,887 |  | 29,543
Other debtors |  |  |  | - |  | 1,516
|  |  |  | 185,118 |  | 196,734

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |  |  |  |  |  |
|  |  |  | 2025 |  | 2024
|  |  |  | £ |  | £
UK corporation tax |  |  |  | 15,344 |  | 291
PAYE control |  |  |  | 1,455 |  | 1,241
Directors current account |  |  |  | 341,461 |  | 341,481
Trade creditors |  |  |  | 129,572 |  | 136,958
Other creditors |  |  |  | 5,500 |  | 5,783
|  |  |  | 493,332 |  | 485,754

8. PROVISIONS FOR LIABILITIES |  |  |  | 2025 |  | 2024
|  |  |  | £ |  | £
Deferred taxation |  |  |  | 818 |  | -
|  |  |  | 818 |  | -

9. SHARE CAPITAL |  |  |  | 2025 |  | 2024
|  |  |  | £ |  | £
Allotted, issued and fully paid: |  |  |  |  |  |
100 Ordinary shares of £1 each |  |  |  | 100 |  | 100
|  |  |  | 100 |  | 100

Sunrise Pharma Limited

10. CONTROLLING PARTY
The company's ultimate controlling party is the majority shareholder Dr Satish Kumar Narang.